Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2011 | 1 |
2012 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study.
Lancet Glob Health. 2022 Jul;10(7):e1003-e1011. doi: 10.1016/S2214-109X(22)00168-1. Epub 2022 May 24.
Lancet Glob Health. 2022.
PMID: 35623378
Free PMC article.
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.
GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery.
GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery.
Lancet. 2021 Jan 30;397(10272):387-397. doi: 10.1016/S0140-6736(21)00001-5. Epub 2021 Jan 21.
Lancet. 2021.
PMID: 33485461
Free PMC article.
Item in Clipboard
A common allele increases endometrial Wnt4 expression, with antagonistic implications for pregnancy, reproductive cancers, and endometriosis.
Pavličev M, McDonough-Goldstein CE, Zupan AM, Muglia L, Hu YC, Kong F, Monangi N, Dagdas G, Zupančič N, Maziarz J, Sinner D, Zhang G, Wagner G, Muglia L.
Pavličev M, et al.
Nat Commun. 2024 Feb 12;15(1):1152. doi: 10.1038/s41467-024-45338-4.
Nat Commun. 2024.
PMID: 38346980
Free PMC article.
Item in Clipboard
A new boson with a mass of 125 GeV observed with the CMS experiment at the Large Hadron Collider.
CMS Collaboration.
CMS Collaboration.
Science. 2012 Dec 21;338(6114):1569-75. doi: 10.1126/science.1230816.
Science. 2012.
PMID: 23258887
Free article.
Item in Clipboard
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.
Bousser MG, et al.
Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25.
Lancet. 2011.
PMID: 21616527
Clinical Trial.
Item in Clipboard
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators.
Bousser MG, et al.
Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16.
Cerebrovasc Dis. 2009.
PMID: 19372653
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite